Ascentage Pharma Group International Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 13.84 K | $243.05 K | -13.80% | 0.01% |
| MORGAN STANLEY | 08/13/2026 | 919 | $16.14 K | 84.54% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 200 | $3.51 K | 100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 07/24/2026 | 24 | $421 | 0.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 15 | $263 | -87.90% | 0.00% |
| BLACKROCK, INC. | 08/07/2026 | 6 | $105 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 1 | $18 | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| XY CAPITAL LTD | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ascentage Pharma Group International institutional Ownership - FAQ's
During the previous two years, 10 institutional investors and hedge funds held shares of Ascentage Pharma Group International. The most heavily invested institutionals were:
Point72 Asset Management, L.P.: 13,841
MORGAN STANLEY: 919
WELLS FARGO & COMPANY/MN: 200
EverSource Wealth Advisors, LLC: 24
UBS Group AG: 15
BlackRock, Inc.: 6
0.02% of Ascentage Pharma Group International stock is owned by institutional investors.
Institutional investors have bought a total of 32.94 K shares in the last 24 months. This purchase volume represents approximately $780.25 K in transactions.